SCHEMBL6511554

SCHEMBL6511554

Cn1c(/C=C/c2ccc(C(=O)O)cc2)c([N+](=O)[O-])c(=O)n(C)c1=O

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.67
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPK1 P28482 1/20 0.67
SMN1; SMN2 Q16637 2/20 0.63
POLB P06746 1/20 0.63
LMNA P02545 2/20 0.60
MITF O75030 1/20 0.59
NCOA1 Q15788 1/20 0.58
NCOA3 Q9Y6Q9 1/20 0.58
FBP1 P09467 1/20 0.48
MAOB P27338 1/20 0.42
ADORA2A P29274 1/20 0.42
PTPN1 P18031 1/20 0.41
PTPN12 Q05209 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511560 1.00 MAPT (0.67) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL4057527 0.85 MITF (0.74) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL4057528 0.85 MITF (0.74) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL24451139 0.83 MAPT (0.72) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL6509384 0.76 MAPT (0.78) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL6509381 0.76 MAPT (0.78) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL17616161 0.75 MEN1 (1.00) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL9134846 0.71 TDP1 (0.78) MAPTMEN1KMT2AFBP1MAOB
SCHEMBL9134841 0.71 TDP1 (0.78) MAPTMEN1KMT2AFBP1MAOB
SCHEMBL11196588 0.70 FBP1 (0.49) FBP1PTPN1PTPN12PTPN22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ALMIRALL PRODESFARMA S.A. (ES) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ADORA1, ADORA2A, P2RY10 MAPT 4800/4885MEN1 4659/4885KMT2A 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.